CTLA4 and neoplasm: Ligation of adenosine receptors (A2aR and A2bR) on the surface of anti-tumor T cells subsequently triggers the upregulation of PD1 and CTLA4 on the T cell surface, resulting in the inhibition of IFN secretion and collectively culminating in the functional suppression of the anti-tumoral response (9–13).